NovAccess Global (XSNX) Stock Price & Analysis

14 Followers

XSNX Stock Chart & Stats

$0.00$0.00(0.00%)

At close: Oct 12 3:39 PM EDT

Day’s Range: $0.01 - $0.01
52-Week Range: $0.00 - $0.01
Previous Close: $0.01
Volume: N/A
Average Volume (3M): 36.23K
Market Cap: $6,165
Enterprise Value: $2.18T
Total Cash (Recent Filing): $794
Total Debt (Recent Filing): $2.09M
Price to Earnings (P/E): 0.0
Beta: 28.43
Next Earnings: N/A
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

NovAccess Global News

Neil Laird Exits NovAccess Global, Joins Ondas Holdings

An update from NovAccess Global (XSNX) is now available. Neil J. Laird has stepped down as CFO of NovAccess Global Inc. to assume the same position at Ondas Holdings Inc.,

2y ago8K XSNX

NovAccess Global files patent with Cedars-Sinai

NovAccess Global has submitted a provisional patent for new intellectual property developed at Cedars-Sinai to advance the Company’s immunotherapy platform. The patent pertains to the use of a specific protein,

2y agoXSNX

NovAccess Global announces license to advance immunotherapy platform

NovAccess Global announced the procurement of a new intellectual property license from Cedars-Sinai Medical Center to further advance the Company’s immunotherapy platform. The license pertains to the use of Isocitrate

2y agoXSNX

NovAccess Global says financing transaction with Sumner remains pending

NovAccess Global provided an update on business developments, financing and the 2024 annual meeting. The previously disclosed $10.7 million financing transaction with Sumner Global LLC remains pending, as Sumner Global

2y agoXSNX

NovAccess Global Faces Default and Uncertain Rescue Deal

NovAccess Global (XSNX) has released an update to notify the public and investors about events prompting financial liability intensification. NovAccess Global Inc. is facing financial difficulties, having defaulted on a

2y ago8K XSNX

NovAccess Global announces $10.7M financing

NovAccess Global entered into a securities purchase agreement with an affiliate of Sumner Global for a total financing of $10.7M. Pursuant to the agreement, Sumner agreed to purchase 33M newly

2y agoXSNX

NovAccess Global appoints Roscoe Moore to scientific advisory board

NovAccess Global announced the appointment of Dr. Roscoe M. Moore, Jr., to its Scientific Advisory Board. Dr. Moore was a career officer within the Commissioned Corps of the United States

2y agoXSNX

NovAccess Global, BCN Biosciences partner for immunotherapy platform

NovAccess Global announced the signing of a Letter of Intent and formation of a partnership with BCN Biosciences to expand its immunotherapy platform. Utilizing BCN’s small molecule drug BCN057, developed

3y agoXSNX

NovAccess Global CEO to present at World Orphan Drug Congress

NovAccess Global announced that its CEO Dr. Dwain Irvin has been invited to present at the World Orphan Drug Congress, scheduled for May 23-25, 2023, near Washington, DC. Dr. Christopher

3y agoXSNX

XSNX FAQ

What was NovAccess Global’s price range in the past 12 months?

NovAccess Global lowest stock price was $0.00 and its highest was $0.01 in the past 12 months.

What is NovAccess Global’s market cap?

NovAccess Global’s market cap is $6,165.

When is NovAccess Global’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

Is NovAccess Global overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does NovAccess Global pay dividends?

NovAccess Global does not currently pay dividends.

What is NovAccess Global’s EPS estimate?

NovAccess Global’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does NovAccess Global have?

NovAccess Global has 61,652,386 shares outstanding.

Which hedge fund is a major shareholder of NovAccess Global?

Currently, no hedge funds are holding shares in XSNX

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description